By the end of the day, ZONA was up only 3/4 on this news. I'm not knocking the $5 million milestone payment but milestone payments aren't what will make ZONA worth this stock price. I believe the stock price will erode from now till FDA's decision, as I outlined before.
The estimate of 25% of Viagra sales in the news item Craig posted, is pure wishful thinking. With such a lower success rate and being tried only on people who failed with Viagra, it would be amazing if Vasomax obtained 2% of Viagra's sales.
What tests were done on people who fail with Viagra to see how many of them are helped by Vasomax? Viagra is supposed to help a wider population than Vasomax, in helping mild to moderate cases of ED. Vasomax, if it helps anyone (dubious that it does), only mild cases. So those that fail with Viagra are in my opinion likely to be the moderate to severe cases, leaving almost nothing of Vasomax' mild population unhelped by Viagra. So, Vasomax may help almost no one who wasn't helped by Viagra (assuming it works at all, which is questionable).
That 25% figure is pure hype but that will be shown only if the drug is approved, I guess, so we won't have the proof of the accuracy of what I'm saying for two years, if ever.
Linda |
